The Four Corners Sign A Specific Imaging Feature in Differentiating Systemic Sclerosis-related Interstitial Lung Disease From Idiopathic Pulmonary Fibrosis

被引:24
作者
Walkoff, Lara [1 ]
White, Darin B. [1 ]
Chung, Jonathan H. [3 ]
Asante, Dennis [2 ]
Cox, Christian W. [1 ]
机构
[1] Mayo Clin, Dept Radiol, 200 First St SW, Rochester, MN 55905 USA
[2] Mayo Clin, Robert D & Patricia E Kern Ctr Sci Hlth Care Deli, Hlth Sci Res, Rochester, MN USA
[3] Univ Chicago Med, Dept Radiol, Chicago, IL USA
关键词
idiopathic pulmonary fibrosis; systemic sclerosis; interstitial lung disease; IDIOPATHIC PULMONARY-FIBROSIS; CONNECTIVE-TISSUE DISEASE; LUNG-DISEASE; CT; CLASSIFICATION; PNEUMONIA; SURVIVAL; CRITERIA;
D O I
10.1097/RTI.0000000000000319
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Purpose: Differentiating between systemic sclerosis-related interstitial lung disease (SSc-ILD) and idiopathic pulmonary fibrosis (IPF) is important because of the differences in workup, prognosis, and treatment. However, there is much overlap in the appearance of these 2 entities on high-resolution computed tomography. We propose that inflammation and/or fibrosis focally or disproportionately involving the bilateral anterolateral upper lobes and posterosuperior lower lobes [Four Corners Sign (FCS)] is specific for SSc-ILD. Materials and Methods: Randomized high-resolution computed tomography studies from 74 IPF and 73 SSc-ILD cases were evaluated by 2 thoracic radiologists blinded to all patient data. For each case the reviewers noted whether the FCS was present and assigned a confidence level on the basis of a 7-point Likert scale. The same process was then performed on a randomized external validation group of 42 SSc-ILD and 42 IPF cases. Results: For Likert scores of 6 or 7 (mostly agree or entirely agree that the FCS is present, respectively) the sensitivity in SSc was 16.4% (95% confidence interval, 9.7%, 26.6%), specificity 100.0% (95% confidence interval, 95.1%, 100.0%). There was a significant association between a confidently present FCS and SSc compared with a confidently present FCS and IPF (P = 0.0003). Analysis on an external validation group of 42 SSc and 42 IPF cases conferred similarly high specificity for SSc in cases characterized as FCS with high confidence. Conclusion: The FCS, a pattern of focal or disproportionate inflammation and/or fibrosis involving the bilateral anterolateral upper lobes and posterosuperior lower lobes, is specific for SSc-ILD when readers are confident of its presence.
引用
收藏
页码:197 / 203
页数:7
相关论文
共 50 条
  • [31] Induced sputum as a method for detection of systemic sclerosis-related interstitial lung disease
    Yilmaz, Neslihan
    Abul, Yasin
    Bicakcigil, Muge
    Golabi, Pejman
    Celikel, Cigdem
    Karakurt, Sait
    Yavuz, Sule
    RHEUMATOLOGY INTERNATIONAL, 2012, 32 (07) : 1921 - 1925
  • [32] Nailfold Videocapillaroscopy Changes Are Associated With the Presence and Severity of Systemic Sclerosis-Related Interstitial Lung Disease
    Caetano, Joana
    Paula, Filipe S.
    Amaral, Marta
    Oliveira, Susana
    Alves, Jose D.
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2019, 25 (03) : E12 - E15
  • [33] Prognosis of patients with systemic sclerosis-related interstitial lung disease on the lung transplant waiting list: a retrospective study
    Nakayama, Yoichi
    Nakashima, Ran
    Handa, Tomohiro
    Ohsumi, Akihiro
    Yamada, Yoshito
    Nakajima, Daisuke
    Yutaka, Yojiro
    Tanaka, Satona
    Hamada, Satoshi
    Ikezoe, Kohei
    Tanizawa, Kiminobu
    Shirakashi, Mirei
    Hiwa, Ryosuke
    Tsuji, Hideaki
    Kitagori, Koji
    Akizuki, Shuji
    Yoshifuji, Hajime
    Date, Hiroshi
    Morinobu, Akio
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [34] Chemokine receptor CXCR4 based positron emission tomography imaging in systemic sclerosis-related interstitial lung disease
    Kopp, Chirag Rajkumar
    Sharma, Shefali Khanna
    Krishnaraju, Venkata Subramanian
    Sood, Ashwani
    Kumar, Rajender
    Sinha, Anindita
    Dhooria, Sahajal
    Singh, Jagdeep
    Anand, Shashi
    Minz, Ranjana Walker
    Dhir, Varun
    Jain, Sanjay
    RHEUMATOLOGY, 2024,
  • [35] Rituximab in the treatment of systemic sclerosis-related interstitial lung disease: a systematic review and meta-analysis
    Goswami, Rudra P.
    Ray, Animesh
    Chatterjee, Moumita
    Mukherjee, Arindam
    Sircar, Geetabali
    Ghosh, Parasar
    RHEUMATOLOGY, 2021, 60 (02) : 557 - 567
  • [36] Association of Symptoms of Gastroesophageal Reflux, Esophageal Dilation, and Progression of Systemic Sclerosis-Related Interstitial Lung Disease
    Volkmann, Elizabeth R.
    Tashkin, Donald P.
    Leng, Mei
    Kim, Grace Hyun J.
    Goldin, Jonathan
    Roth, Michael D.
    ARTHRITIS CARE & RESEARCH, 2023, : 1690 - 1697
  • [37] Systemic sclerosis-related interstitial lung disease: Diagnostic and therapeutic strategy in the light of recent clinical trials
    Lescoat, A.
    Jouneau, S.
    Uzunhan, Y.
    Jego, P.
    Cottin, V.
    Hachulla, E.
    REVUE DE MEDECINE INTERNE, 2022, 43 (06): : 365 - 374
  • [38] Review: Serum biomarkers in idiopathic pulmonary fibrosis and systemic sclerosis associated interstitial lung disease - frontiers and horizons
    Jee, Adelle S.
    Sahhar, Joanne
    Youssef, Peter
    Bleasel, Jane
    Adelstein, Stephen
    Maianh Nguyen
    Corte, Tamera J.
    PHARMACOLOGY & THERAPEUTICS, 2019, 202 : 40 - 52
  • [39] Comparative analysis of connective tissue disease-associated interstitial lung disease and idiopathic pulmonary fibrosis from a tertiary care centre in Pakistan
    Zubairi, Ali Bin Sarwar
    Ahmad, Huzaifa
    Hassan, Maryam
    Siddiqui, Faraz
    Iqbal, Nousheen
    Riaz, Mehmood
    Irfan, Muhammad
    JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION, 2021, 71 (10) : 2330 - 2334
  • [40] PROGNOSIS OF PATIENTS WITH SYSTEMIC SCLEROSIS-RELATED INTERSTITIAL LUNG DISEASE AFTER THE LUNG TRANSPLANTATION: A RETROSPECTIVE STUDY
    Nakayama, Y.
    Nakashima, R.
    Handa, T.
    Ohsumi, A.
    Yamada, Y.
    Nakajima, D.
    Yutaka, Y.
    Tanaka, S.
    Hamada, S.
    Ikezoe, K.
    Tanizawa, K.
    Shirakashi, M.
    Hiwa, R.
    Tsuji, H.
    Kitagori, K.
    Akizuki, S.
    Yoshifuji, H.
    Date, H.
    Morinobu, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 160 - 161